Table 3. Related risk factor-related parameters (P<0.05) associated with hepatocellular carcinoma early recurrence after curative hepatectomy in the training set.
Factors | Beta | SE | Z value | Probability (>|Z|) |
---|---|---|---|---|
Age | −0.42 | 0.24 | −1.75 | 0.08 |
TMN stage | 0.03 | 0.20 | 0.15 | 0.88 |
AFP | 0.14 | 0.17 | 0.84 | 0.40 |
Tumor number | 0.55 | 0.19 | 2.88 | <0.01 |
Tumor capsule | 0.94 | 0.43 | 2.20 | 0.03 |
Tumor size | 0.16 | 0.06 | 2.93 | <0.01 |
Portal vein tumor thrombi | −1.44 | 0.73 | −1.97 | 0.05 |
Pathological grade | 0.47 | 0.29 | 1.64 | 0.10 |
Vascular tumor emboli | −0.86 | 0.35 | −2.58 | 0.01 |
Preoperative neo-adjuvant chemotherapy | 0.73 | 0.67 | 1.08 | 0.28 |
Modus operandi | 0.19 | 0.35 | 0.56 | 0.58 |
Postoperative complication | −0.28 | 0.21 | −1.34 | 0.18 |
Postoperative adjuvant therapy | −0.01 | 0.14 | −0.10 | 0.92 |
AST | >−0.01 | <0.01 | −1.05 | 0.29 |
rGGT | >−0.01 | <0.01 | −0.33 | 0.74 |
ALP | <0.01 | <0.01 | 1.49 | 0.14 |
APTT | 0.08 | 0.03 | 2.30 | 0.02 |
INR | −0.34 | 1.16 | −0.29 | 0.77 |
WBC | 0.04 | 0.07 | 0.59 | 0.56 |
PLT | >−0.01 | <0.01 | −0.85 | <0.01 |
Beta represents the standardized coefficient. SE, standard error; AFP, alpha-fetoprotein; AST, alanine aminotransferase; GGT, gamma-glutamyl transpeptidase; ALP, alkaline phosphatase; APTT, activated partial thromboplastin time; INR, international normalized ratio; WBC, white blood cell; PLT, platelet.